Federal contract award
HT001424F0014
ANCILLARY MEDICAL SERVICES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 622110 — General Medical and Surgical Hospitals |
| PSC | Q517 — Pharmacy Services |
| Parent award / vehicle | HT005018D0034 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $6.5M |
| Current contract value | $7.5M |
| Potential contract value / ceiling | $11.8M |
| Start date | Nov 1, 2023 |
| Current end date | Oct 31, 2026 |
| Potential end date | Oct 31, 2027 |
| Latest award activity | Mar 30, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 30, 2026 | P00009 | $-326.7K | MEDICAL PROFESSIONAL FULL TIME EQUIVALENTS (FTES) |
| Dec 30, 2025 | P00008 | $2.3M | MEDICAL PROFESSIONAL FULL TIME EQUIVALENTS (FTES) |
| Sep 22, 2025 | P00007 | $161.4K | MEDICAL PROFESSIONAL FULL TIME EQUIVALENTS (FTES) |
| Sep 12, 2025 | P00006 | $-180.2K | MEDICAL PROFESSIONAL FULL TIME EQUIVALENTS (FTES) |
| Oct 31, 2024 | P00005 | $2.1M | PHARMACISTS |
Estimated positioning window
Oct 31, 2026 – Apr 30, 2027
Modeled likelihood: 70%. These are AcornBids estimates, not confirmed solicitation dates.
{
"psc": "Q517",
"naics": "622110",
"agency": "Department of Defense",
"office": "DEFENSE HEALTH AGENCY",
"vehicle": "HT005018D0034",
"incumbent": "MATRIX PROVIDERS INC.",
"known_forecast": false,
"option_end_date": "2027-10-31",
"contract_end_date": "2027-10-31",
"latest_action_date": "2026-03-30",
"modification_count": 5,
"previous_solicitation": "HT005016R0001",
"historical_award_count": 3,
"historical_cadence_days": 837
}Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.